Rezolute (RZLT) has issued an announcement.
Rezolute, Inc. is set to make waves in the financial markets with its latest announcement: Dr. Paul Thornton will present the Phase 2 RIZE study results at the upcoming Pediatric Endocrine Society Annual Meeting. This highly anticipated event, scheduled for May 2024 in Chicago, is expected to draw significant interest from both medical and investment communities.
See more insights into RZLT stock on TipRanks’ Stock Analysis page.
